Skip to main content



The Cost of FDA-Approved CBD

As CBD Journal reported back in June, the FDA has approved the use of a CBD-based drug called Epidiolex for the treatment of two of the hardest-to-treat forms of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome. According to a story in the New York Times, makers of the drug, British-based GW Pharmaceuticals, says the drug will cost roughly $32,500 per year.


This Is The World's First FDA-Approved CBD Medication

FDA officials finally approved the world’s first CBD-based drug, Epidiolex, developed by pharmaceutical-maker by GW Pharmaceuticals. The drug is designed for use in treating two severe forms of childhood epilepsy and is the very first FDA-approved medication that contains a purified cannabinoid derived from cannabis. Moreover, it is the first FDA approval of any drug specifically meant to treat Dravet syndrome, one of the aforementioned forms of epilepsy.

Subscribe to Epidiolex